Cannabis
Posted on September 07, 2012 by Akashma Online News
Posted by Marivel Guzman
Marijuana, or cannabis, as it is more appropriately called, has been part of humanity’s medicine chest for almost as long as history has been recorded.
Of all the negative consequences of marijuana prohibition, none is as tragic as the denial of medicinal cannabis to the tens of thousands of patients who could benefit from its therapeutic use.
Modern research suggests that cannabis is a valuable aid in the treatment of a wide range of clinical applications. These include pain relief — particularly of neuropathic pain (pain from nerve damage) — nausea, spasticity, glaucoma, and movement disorders. Marijuana is also a powerful appetite stimulant, specifically for patients suffering from HIV, the AIDS wasting syndrome, or dementia. Emerging research suggests that marijuana’s medicinal properties may protect the body against some types of malignant tumors and are neuroprotective.
Currently, more than 60 U.S. and international health organizations support granting patients immediate legal access to medicinal marijuana under a physician’s supervision.
Medical Frequently Asked Questions
Find out the essentials on medical marijuana. Read more
Emerging Clinical Applications
Marijuana Laws & Penalties
Arrests and Crop Data
California NORML Chapters
Marijuana Lawyers in California
END MARIJUANA PROHIBITION!
Tell our elected officials how you feel
The next NORML event is:
NORML’s online network
Phone: (202) 483-5500 • Fax: (202) 483-0057
Akashma Online News 
US Government Patent on Cannabinoids
The U.S. Government, as represented by the Department of Health and Human Services (D H H S), filed for a patent on cannabinoids as anti-oxidants and neuroprotectants. U.S. Patent 6630507
Abstract
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuro-protectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Non-psychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuro-protective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH.sub.3, and COCH.sub.3. ##STR1##
Inventor: Hampson; Aidan J. (Irvine, CA), Axelrod; Julius (Rockville, MD), Grimaldi; Maurizio (Bethesda, MD)
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
Family ID: 26767641
Appl. No.: 09/674,028
Filed: February 2, 2001
PCT Filed: April 21, 1999
PCT No.: PCT/US99/08769
PCT Pub. No.: WO99/53917
PCT Pub. Date: October 28, 1999
from: http://green-bloom.com/us-government-patent-on-cannabinoids/
LikeLike